• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Eli Lilly

Eli Lilly

Principal Large Cap Growth R3 PLGPX 2 Star

Last Price$10.20Day Change (%)0.30%
Open Price$10.20Day Change ($)0.03
Day Range10.20–10.2052-Week Range8.66–10.44

As of Fri 05/26/2017 | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Opioids are still the best pain drug we've got

    Opioids are still the best pain drug we've got

  2. UPDATE: Opioids are ravaging the U.S., but they're still the best pain drug we've got

    UPDATE: Opioids are ravaging the U.S., but they're still the best pain drug we've got

  3. UPDATE: Opioids are ravaging the U.S., but they're still the best pain drug we've got

    UPDATE: Opioids are ravaging the U.S., but they're still the best pain drug we've got

  4. UPDATE: Opioids are ravaging the U.S., but they're still the best pain drug we've got

    UPDATE: Opioids are ravaging the U.S., but they're still the best pain drug we've got

  5. UPDATE: Opioids are ravaging the U.S., but they're still the best pain drug we've got

    UPDATE: Opioids are ravaging the U.S., but they're still the best pain drug we've got

  6. World Lung Cancer Therapeutics Market Opportunities and Forecasts 2014-2017 & 2022: Leading Companies are Roche, Merck, AstraZeneca, Sanofi-Aventis, Eli Lilly and Co, Pfizer, and Agennix - Research ...

    World Lung Cancer Therapeutics Market Opportunities and Forecasts 2014-2017 & 2022: Leading Companies are Roche, Merck, AstraZeneca, Sanofi-Aventis, Eli Lilly and Co, Pfizer, and Agennix - Research and Markets

  7. Health Care Higher as Regulatory Fears Recede -- Health Care Roundup

    Health Care Higher as Regulatory Fears Recede -- Health Care Roundup

  8. Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market to 2021- Strategic Analysis of Industry Trends, Technologies, Participants, and Environment - Research and Markets

    Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market to 2021- Strategic Analysis of Industry Trends, Technologies, Participants, and Environment - Research and Markets

  9. Global Endometrial Cancer Therapeutics Market to Reach $27 Billion by 2021 - Obesity Fuelling Endometrial Cancer Incidences - Research and Markets

    Global Endometrial Cancer Therapeutics Market to Reach $27 Billion by 2021 - Obesity Fuelling Endometrial Cancer Incidences - Research and Markets

  10. Global Anxiety and Panic Disorders Drugs Market - Analysis, Technologies & Forecasts to 2021 - Key Vendors are AstraZeneca, Eli Lilly , GlaxoSmithKline & Pfizer - Research and Markets

    Global Anxiety and Panic Disorders Drugs Market - Analysis, Technologies & Forecasts to 2021 - Key Vendors are AstraZeneca, Eli Lilly , GlaxoSmithKline & Pfizer - Research and Markets

12345

©2017 Morningstar Advisor. All right reserved.